NanoViricides, Inc. (NNVC) financial statements (2020 and earlier)

Company profile

Business Address 1 CONTROLS DRIVE
SHELTON, CT 06484
State of Incorp. NV
Fiscal Year End June 30
SIC 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13715243137
Cash and cash equivalents13715243137
Prepaid expense0000000
Other current assets      0
Other undisclosed current assets0     1
Total current assets:13715243238
Noncurrent Assets
Property, plant and equipment1010111112125
Intangible assets, net (including goodwill)0000000
Intangible assets, net (excluding goodwill)0000000
Other undisclosed noncurrent assets0000001
Total noncurrent assets:1011111212137
TOTAL ASSETS:12131927374445
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1000000
Accounts payable1000000
Accrued liabilities0000000
Interest and dividends payable   000 
Debt    5  
Derivative instruments and hedges, liabilities    0 6
Due to related parties1100101
Other undisclosed current liabilities2204  (6)
Total current liabilities:4315711
Noncurrent Liabilities
Liabilities, other than long-term debt      6
Derivative instruments and hedges, liabilities      6
Other undisclosed noncurrent liabilities   27129
Total noncurrent liabilities:   271215
Total liabilities:4317141216
Stockholders' equity
Stockholders' equity attributable to parent, including:8111820233229
Common stock0000000
Additional paid in capital10310310195888681
Retained earnings (accumulated deficit)(96)(92)(84)(75)(65)(54)52
Other undisclosed stockholders' equity attributable to parent000000(105)
Total stockholders' equity:8111820233229
TOTAL LIABILITIES AND EQUITY:12131927374445

Income statement (P&L) ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Operating expenses(8)(9)(9)(10)(9)(7)(9)
Operating loss:(8)(9)(9)(10)(9)(7)(9)
Nonoperating income (expense)001(1)(2)5(5)
Other nonoperating income00000  
Interest and debt expense(0) (0)(0)(1)(3)(3)
Loss from continuing operations before equity method investments, income taxes:(8)(8)(9)(11)(12)(5)(17)
Other undisclosed income from continuing operations before income taxes0 00133
Net loss available to common stockholders, basic:(8)(8)(9)(10)(11)(2)(14)
Dilutive securities, effect on basic earnings per share     (3) 
Net loss available to common stockholders, diluted:(8)(8)(9)(10)(11)(5)(14)

Comprehensive Income ($ in millions)

12/31/2019
TTM
6/30/2019
6/30/2018
6/30/2017
6/30/2016
6/30/2015
6/30/2014
Net loss:(8)(8)(9)(10)(11)(2)(14)
Comprehensive loss, net of tax, attributable to parent:(8)(8)(9)(10)(11)(2)(14)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: